hesperetin has been researched along with Breast Cancer in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bideh, M; Khedri, A; Safari, S; Zangooei, M | 1 |
| Amanlou, M; Khorsand, B; Rostamabadi, H; Samandari-Bahraseman, MR; Zareei, S | 1 |
| Elkodairy, KA; Elzoghby, AO; Gaber, M; Hany, M; Helmy, MW; Mokhtar, S | 1 |
| Hermawan, A; Putri, H; Utomo, RY | 1 |
| Hermawan, A; Ilmawati, GPN; Khumaira, A; Meiyanto, E; Nurhayati, IP | 1 |
| Chen, Z; Di, G; Fan, J; Guo, C; Li, Q; Qi, X; Wang, J; Wu, X | 1 |
| Abdallah, RM; Assal, RA; El Mechawy, N; El Sebaei, A; El-Askary, H; Elkhouly, AM; Motaal, AA; Soliman, RA; Youness, RA | 1 |
| Chiu-Leung, LC; Leung, LK; Lin, SM; Tan, YQ | 1 |
| Das, PK; Kar, S; Palit, S; Sharma, G | 1 |
| Boom, K; Borsoi, C; Celia, C; Ferrari, M; Fresta, M; Grande, R; Scott, B; Shen, H; Shen, J; Suri, K; Wolfram, J; Zhao, Y | 1 |
| Leung, LK; Li, F; Lin, SM; Ye, L | 1 |
| Chan, FL; Chen, S; Leung, LK; Ye, L | 1 |
| Chan, FL; Chen, S; Cheung, WH; Chow, S; Leung, LK; Li, F | 1 |
| Choi, EJ | 1 |
| Carroll, KK; Chambers, AF; Guthrie, N; Moussa, M; So, FV | 1 |
15 other study(ies) available for hesperetin and Breast Cancer
| Article | Year |
|---|---|
The effect of hesperetin on estrogen receptor gene expression and its relationship with the downstream pathways of estrogen receptor alpha.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression; Humans; Interleukin-6; Receptors, Estrogen | 2023 |
Various concentrations of hesperetin induce different types of programmed cell death in human breast cancerous and normal cell lines in a ROS-dependent manner.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Hesperidin; Humans; Molecular Docking Simulation; Reactive Oxygen Species; Superoxide Dismutase | 2023 |
Boronic-targeted albumin-shell oily-core nanocapsules for synergistic aromatase inhibitor/herbal breast cancer therapy.
Topics: Albumins; Androstadienes; Antineoplastic Agents, Phytogenic; Aromatase Inhibitors; Boron; Breast Neoplasms; Female; Hesperidin; Humans; MCF-7 Cells; Nanocapsules; Phospholipids | 2019 |
Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance.
Topics: Breast Neoplasms; Cell Line, Tumor; Computational Biology; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Ontology; Hesperidin; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Signal Transduction | 2020 |
Cytotoxic and Antimetastatic Activity of Hesperetin and Doxorubicin Combination Toward Her2 Expressing Breast Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Movement; Cell Proliferation; Doxorubicin; Female; Hesperidin; Humans; Receptor, ErbB-2; Tumor Cells, Cultured | 2020 |
Improved bioavailability and anticancer efficacy of Hesperetin on breast cancer via a self-assembled rebaudioside A nanomicelles system.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diterpenes, Kaurane; Drug Carriers; Drug Compounding; Drug Liberation; Female; Hesperidin; Humans; Membrane Potential, Mitochondrial; Mice; Micelles; Nanoparticles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Solubility; Tissue Distribution; Tumor Burden | 2021 |
Hindering the Synchronization Between miR-486-5p and H19 lncRNA by Hesperetin Halts Breast Cancer Aggressiveness Through Tuning ICAM-1.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Female; Hesperidin; Humans; Intercellular Adhesion Molecule-1; MicroRNAs; Middle Aged; RNA, Long Noncoding; Tumor Cells, Cultured | 2022 |
The citrus flavonone hesperetin attenuates the nuclear translocation of aryl hydrocarbon receptor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Active Transport, Cell Nucleus; Antineoplastic Agents, Phytogenic; Basic Helix-Loop-Helix Transcription Factors; Breast Neoplasms; Carcinogens, Environmental; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Dietary Supplements; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hesperidin; Humans; MCF-7 Cells; Microscopy, Confocal; Neoplasm Proteins; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon | 2018 |
Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Enzyme Activation; Flow Cytometry; Hesperidin; Humans; Immunoblotting; Immunoprecipitation; In Situ Nick-End Labeling; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; MCF-7 Cells; Membrane Potential, Mitochondrial; Reactive Oxygen Species; RNA, Small Interfering; Transfection | 2015 |
Hesperetin Liposomes for Cancer Therapy.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Compounding; Drug Resistance, Neoplasm; Female; Hesperidin; Humans; Kinetics; Liposomes; Lung Neoplasms; Phosphatidylcholines; Polyethylene Glycols; Solubility; Transfection | 2016 |
Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7.
Topics: Apigenin; Aromatase; Aromatase Inhibitors; Breast Neoplasms; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Enzyme Assays; Female; Flavanones; Genes, Reporter; Hesperidin; Humans; Luciferases, Firefly; Luteolin; Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Transcription Factor AP-1; Transcription, Genetic | 2011 |
The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice.
Topics: Animals; Aromatase; Aromatase Inhibitors; bcl-X Protein; Breast Neoplasms; Cell Proliferation; Citrus; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p57; Estradiol; Estrogens; Female; Hesperidin; Humans; MCF-7 Cells; Mice; Mice, Nude; Ovariectomy; RNA, Messenger; Xenograft Model Antitumor Assays | 2012 |
The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Citrus; Estradiol; Female; Hesperidin; Humans; Letrozole; MCF-7 Cells; Mice; Mice, Nude; Nitriles; Osteoporosis; Selective Estrogen Receptor Modulators; Triazoles; Xenograft Model Antitumor Assays | 2013 |
Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Female; G1 Phase; Hesperidin; Humans; Time Factors | 2007 |
Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Beverages; Breast Neoplasms; Cell Division; Citrus; Female; Flavanones; Flavonoids; Genistein; Hesperidin; Humans; Isoflavones; Mammary Neoplasms, Experimental; Quercetin; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1996 |